Linking the value of ADC technology to its pioneer and to the patients who will benefit

The client

ImmunoGen, a leader in antibody drug conjugate (ADC) technology.

The challenge

Expand ImmunoGen's reputation as a pioneer in ADC technology to one that is commercializing innovative therapies by pursuing new targets.

The result

Evolved visual identity and messaging was launched at ASCO eliciting positive responses from key stakeholders, including clinical investigators, the investment community, and industry partners. We visually communicated how ADCs work, what the benefits are currently and what might be possible in the near future, which helped foster new partnerships.

The elements

Updated MOA visualization, look and feel, and clinical trial logos were featured in exhibit booth design and panels (print and digital), scientific posters, corporate pipeline brochure, infographic ads, annual report, invitations, e-mails, and collateral materials.